Global Neuromodulation Market 2020
According to the new report by RNCOS entitled, “Global Neuromodulation Market 2020,” the Neuromodulation/Neurostimulation industry is set to revolutionize the healthcare domain and to reach US$ 6.5 Billion by 2020. Neuromodulation directly influences the body’s regulation systems by applying electrical signals to target nerves. The therapy provides relief to patients from pain and accompanying side-effects of drugs. The technology used is expected to replace conventional treatments for neurological disorders in the near future.
Furthermore, RNCOS report covers an exhaustive research into different types of Neuromodulation procedures and their applications. Thereafter, based on the type of procedure, the market is segmented into internal and external neurostimulation. In terms of applications, the industry is bifurcated primarily into sacral nerve stimulation, deep brain stimulation and vague nerve stimulation, among others. Geographically, North America dominated the industry covering 41% of the global market last year.
Also, rising incidences of Alzheimer’s and Parkinson syndromes, a growing ageing population, increasing awareness, and expanding applications of neurostimulation devices are key contributors to the industry’s growth. The study provides a detailed description of the market size, segmentation, mergers & acquisitions, industry developments and major hurdles facing the industry. A separate section is devoted to the competitive landscape, including key players and their past five year revenue growth. Another analysis revealed that Medtronic led the market in 2014 whereas Cyberonics witnessed the highest CAGR in the market for the last five years. Other players in the competition include Boston Scientific, Nevro, Dupoy Synthesis and other small players.
To boost the neuromodulation device industry, later part of the report stresses on recommendations proposed by RNCOS’ analysts. The 63 page study will enlighten readers about the latest developments, emerging markets, and potential growth segments in the global neuromodulation industry. The study is expected to generate a deep interest within those investors who are planning to draw significant profit from this industry.
Furthermore, RNCOS report covers an exhaustive research into different types of Neuromodulation procedures and their applications. Thereafter, based on the type of procedure, the market is segmented into internal and external neurostimulation. In terms of applications, the industry is bifurcated primarily into sacral nerve stimulation, deep brain stimulation and vague nerve stimulation, among others. Geographically, North America dominated the industry covering 41% of the global market last year.
Also, rising incidences of Alzheimer’s and Parkinson syndromes, a growing ageing population, increasing awareness, and expanding applications of neurostimulation devices are key contributors to the industry’s growth. The study provides a detailed description of the market size, segmentation, mergers & acquisitions, industry developments and major hurdles facing the industry. A separate section is devoted to the competitive landscape, including key players and their past five year revenue growth. Another analysis revealed that Medtronic led the market in 2014 whereas Cyberonics witnessed the highest CAGR in the market for the last five years. Other players in the competition include Boston Scientific, Nevro, Dupoy Synthesis and other small players.
To boost the neuromodulation device industry, later part of the report stresses on recommendations proposed by RNCOS’ analysts. The 63 page study will enlighten readers about the latest developments, emerging markets, and potential growth segments in the global neuromodulation industry. The study is expected to generate a deep interest within those investors who are planning to draw significant profit from this industry.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. NEUROMODULATION- AN INTRODUCTION
4. DRIVERS & CHALLENGES
4.1 Drivers
4.1.1 Inclining Healthcare Expenditure
4.1.2 Growing Geriatric Population
4.1.3 Dramatic Increase in Neurological Disorders
4.1.4 Expanding Applications of Neuromodulation Therapy
4.2 Challenges
4.2.1 Declining Reimbursements in Healthcare
4.2.2 Slashing Hospital Budgets
4.2.3 Limited Access in Rural Hospitals
4.2.4 Shortage of Skilled Professionals
5. NEUROMODULATION MARKET OVERVIEW
6. MARKET SEGMENTATION
6.1 By Technologies
6.1.1 Internal Neuromodulation
6.1.2 Internal Neuromodulation Market By Applications
6.1.2.1 Spinal Cord Stimulation
6.1.2.2 Deep Brain Stimulation
6.1.2.3 Sacral Nerve Stimulation
6.1.2.4 Vagus Nerve Stimulation
6.1.3 External Neuromodulation
6.2 By Geography
6.2.1 US
6.2.2 Europe
6.2.3 Asia-Pacific
6.2.4 Rest of World
7. TRENDS & DEVELOPMENTS
7.1 Startups Set to Revolutionize Market with New Products
7.2 Neuromodulation Improving Treatment for Chronic Pain
7.3 Equity Financing Aiding Innovation in Neuromodulation Market
8. MERGERS & ACQUISITIONS
9. COMPETITIVE ASSESSMENT
9.1 Medtronic
9.2 Boston Scientific
9.3 St. Jude Medical
9.4 Cyberonics
9.5 Nevro
10. RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. NEUROMODULATION- AN INTRODUCTION
4. DRIVERS & CHALLENGES
4.1 Drivers
4.1.1 Inclining Healthcare Expenditure
4.1.2 Growing Geriatric Population
4.1.3 Dramatic Increase in Neurological Disorders
4.1.4 Expanding Applications of Neuromodulation Therapy
4.2 Challenges
4.2.1 Declining Reimbursements in Healthcare
4.2.2 Slashing Hospital Budgets
4.2.3 Limited Access in Rural Hospitals
4.2.4 Shortage of Skilled Professionals
5. NEUROMODULATION MARKET OVERVIEW
6. MARKET SEGMENTATION
6.1 By Technologies
6.1.1 Internal Neuromodulation
6.1.2 Internal Neuromodulation Market By Applications
6.1.2.1 Spinal Cord Stimulation
6.1.2.2 Deep Brain Stimulation
6.1.2.3 Sacral Nerve Stimulation
6.1.2.4 Vagus Nerve Stimulation
6.1.3 External Neuromodulation
6.2 By Geography
6.2.1 US
6.2.2 Europe
6.2.3 Asia-Pacific
6.2.4 Rest of World
7. TRENDS & DEVELOPMENTS
7.1 Startups Set to Revolutionize Market with New Products
7.2 Neuromodulation Improving Treatment for Chronic Pain
7.3 Equity Financing Aiding Innovation in Neuromodulation Market
8. MERGERS & ACQUISITIONS
9. COMPETITIVE ASSESSMENT
9.1 Medtronic
9.2 Boston Scientific
9.3 St. Jude Medical
9.4 Cyberonics
9.5 Nevro
10. RECOMMENDATIONS
LIST OF FIGURES
Figure 5-1: Global - Neuromodulation Market (Billion US$), 2014-2020
Figure 6-1: Global-Neuromodulation Market by Technologies (%), 2014
Figure 6-2: Global-Neuromodulation Market by Technologies (%), 2020
Figure 6-3: Global- Internal Neuromodulation Market (Billion US$) 2014-2020
Figure 6-4: Global - Internal Neuromodulation Market by Applications (%), 2014
Figure 6-5: Global- Internal Neuromodulation Market by Applications (%), 2020
Figure 6-6: Global - Spinal Cord Stimulation Market (Billion US$) 2014-2020
Figure 6-7: Global - Deep Brain Stimulation Market (Million US$) 2014-2020
Figure 6-8: Global - Sacral Nerve Stimulation Market (Million US$) 2014-2020
Figure 6-9: Global - Vagus Nerve Stimulation Market (Million US$) 2014-2020
Figure 6-10: Global - External Neuromodulation Market (Million US$) 2014-2020
Figure 6-11: Global - Neuromodulation Market by Geography (%), 2014
Figure 6-12: Global - Neuromodulation Market by Geography (%), 2020
Figure 6-13: US - Neuromodulation Market (Billion US$) 2014-2020
Figure 6-14: Europe - Neuromodulation Market (Billion US$) 2014-2020
Figure 6-15: Asia-Pacific - Neuromodulation Market (Million US$) 2014-2020
Figure 6-16: ROW - Neuromodulation Market (Million US$) 2014-2020
Figure 9-1: Market Share of Key Players in Global Neuromodulation Market (%), 2014
Figure 9-2: Medtronic Inc - Neuromodulation Revenue (Million US$) 2009 & 2014
Figure 9-3: Medtronic Inc - Breakup of Revenue by Geographies (%), 2014
Figure 9-4: Boston Scientific - Neuromodulation Revenue (Million US$) 2009 & 2014
Figure 9-5: Boston Scientific - Breakup of Revenue by Geographies (%), 2014
Figure 9-6: St Jude Medical - Neuromodulation Revenue (Million US$) 2009 & 2014
Figure 9-7: St Jude Medical - Breakup of Revenue by Geographies (%), 2014
Figure 9-8: Cyberonics - Neuromodulation Revenue (Million US$) 2009 & 2014
Figure 9-9: Cyberonics - Breakup of Revenue by Geographies (%), 2014
Figure 5-1: Global - Neuromodulation Market (Billion US$), 2014-2020
Figure 6-1: Global-Neuromodulation Market by Technologies (%), 2014
Figure 6-2: Global-Neuromodulation Market by Technologies (%), 2020
Figure 6-3: Global- Internal Neuromodulation Market (Billion US$) 2014-2020
Figure 6-4: Global - Internal Neuromodulation Market by Applications (%), 2014
Figure 6-5: Global- Internal Neuromodulation Market by Applications (%), 2020
Figure 6-6: Global - Spinal Cord Stimulation Market (Billion US$) 2014-2020
Figure 6-7: Global - Deep Brain Stimulation Market (Million US$) 2014-2020
Figure 6-8: Global - Sacral Nerve Stimulation Market (Million US$) 2014-2020
Figure 6-9: Global - Vagus Nerve Stimulation Market (Million US$) 2014-2020
Figure 6-10: Global - External Neuromodulation Market (Million US$) 2014-2020
Figure 6-11: Global - Neuromodulation Market by Geography (%), 2014
Figure 6-12: Global - Neuromodulation Market by Geography (%), 2020
Figure 6-13: US - Neuromodulation Market (Billion US$) 2014-2020
Figure 6-14: Europe - Neuromodulation Market (Billion US$) 2014-2020
Figure 6-15: Asia-Pacific - Neuromodulation Market (Million US$) 2014-2020
Figure 6-16: ROW - Neuromodulation Market (Million US$) 2014-2020
Figure 9-1: Market Share of Key Players in Global Neuromodulation Market (%), 2014
Figure 9-2: Medtronic Inc - Neuromodulation Revenue (Million US$) 2009 & 2014
Figure 9-3: Medtronic Inc - Breakup of Revenue by Geographies (%), 2014
Figure 9-4: Boston Scientific - Neuromodulation Revenue (Million US$) 2009 & 2014
Figure 9-5: Boston Scientific - Breakup of Revenue by Geographies (%), 2014
Figure 9-6: St Jude Medical - Neuromodulation Revenue (Million US$) 2009 & 2014
Figure 9-7: St Jude Medical - Breakup of Revenue by Geographies (%), 2014
Figure 9-8: Cyberonics - Neuromodulation Revenue (Million US$) 2009 & 2014
Figure 9-9: Cyberonics - Breakup of Revenue by Geographies (%), 2014
LIST OF TABLES:
Table 7-1: Neuromodulation Products by Startups (2013-2015)
Table 7-2: Equity Financing in Neuromodulation Research (2013-2015)
Table 9-1: Revenue of Major Players in Global Neuromodulation Market (2014)
Table 9-2: Medtronic Inc - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-3: Boston Scientific - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-4: St Jude Medical - Revenue by Business Segments (Million US$), 2013 & 2014
Table 7-1: Neuromodulation Products by Startups (2013-2015)
Table 7-2: Equity Financing in Neuromodulation Research (2013-2015)
Table 9-1: Revenue of Major Players in Global Neuromodulation Market (2014)
Table 9-2: Medtronic Inc - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-3: Boston Scientific - Revenue by Business Segments (Million US$), 2013 & 2014
Table 9-4: St Jude Medical - Revenue by Business Segments (Million US$), 2013 & 2014
